|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 266, Issue 4 1403-R1410, Copyright © 1994 by American Physiological Society
ARTICLES |
K. Matsumura, I. Abe, M. Fukuhara, M. Tominaga, T. Tsuchihashi, K. Kobayashi and M. Fujishima
Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
We examined the role of endogenous opioids in cardiovascular and neurohormonal responses to intracerebroventricular (icv) endothelin-1 (ET-1) in conscious rabbits. With or without pretreatment with intravenous naloxone (1 mg/kg), the effects of icv ET-1 (25 pmol/kg) on cardiovascular and neurohormonal responses were examined. ET-1 (icv) caused significant increases in mean arterial pressure (MAP), renal sympathetic nerve activity (RSNA), plasma catecholamines, and vasopressin levels. Naloxone pretreatment significantly augmented the increases in MAP and RSNA induced by icv ET-1. To clarify the mechanism of these effects, we also examined the effects of naloxone and naloxone methobromide, which does not cross the blood-brain barrier, on baroreceptor reflex. Intravenous naloxone (1 mg/kg) attenuated the baroreflex sensitivity assessed by RSNA (Smax: -9.9 +/- 1.7 vs. -6.9 +/- 1.2, P < 0.01); however, intravenous naloxone methobromide failed to alter the baroreflex sensitivity. Furthermore, in sinoaortic-denervated rabbits, naloxone pretreatment did not affect the increase in MAP induced by (icv) ET-1. These results suggest that intravenous naloxone acts in the central nervous system to attenuate the baroreflex sensitivity, which might augment the increases in MAP and RSNA induced by icv ET-1 in conscious rabbits.
This article has been cited by other articles:
![]() |
K. J. Allahdadi, T. W. Cherng, H. Pai, A. Q. Silva, B. R. Walker, L. D. Nelin, and N. L. Kanagy Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H434 - H440. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shirasaka, T. Kunitake, K. Kato, M. Takasaki, and H. Kannan Nociceptin modulates renal sympathetic nerve activity through a central action in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R1025 - R1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumura, D. B. Averill, and C. M. Ferrario Angiotensin II acts at AT1 receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflex Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1998; 275(5): R1611 - R1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Duport, F. Robert, D. Muller, G. Grau, L. Parisi, and L. Stoppini An in vitro blood-brain barrier model: Cocultures between endothelial cells and organotypic brain slice cultures PNAS, February 17, 1998; 95(4): 1840 - 1845. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |